Triple-negative breast cancer (TNBC) is currently the most malignant subtype of breast
cancer without effective targeted therapies, which makes its pathogenesis an important …

Triple negative breast cancer (TNBC) is a heterogeneous group of breast cancers
characterized by their lack of estrogen receptors, progesterone receptors, and the HER2 …

High recurrence and metastasis of triple-negative breast cancer (TNBC) after operation is a
leading cause of breast cancer related death. The pre-metastatic niche (PMN) is an …

Chronic stress could induce cancer metastasis by constant activation of the sympathetic
nervous system, while cellular mechanism remains obscure. The aim of this research is to …

Triple-negative breast cancer (TNBC) is a highly malignant subtype of breast cancer. High
invasiveness and heterogeneity, as well as a lack of drug targets, are the main factors …

Breast cancer is a collation of malignancies that manifest in the mammary glands at the early
stages. Among breast cancer subtypes, triple-negative breast cancer (TNBC) shows the …

In recent years, triple‐negative breast cancer (TNBC) has emerged as the most aggressive
subtype of breast cancer and is usually associated with increased mortality worldwide. The …

Simple Summary Current data suggest that epigenetic alterations are involved in the
initiation and subclonal evolution of breast cancer. During cancer progression, the …

Abstract Transmembrane TNF-α (tmTNF), a transmembrane form of TNF-α, was reported
overexpressed in approximately 84% of triple-negative breast cancer (TNBC) patients and …

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is an evolutionarily
conserved protein kinase and the most studied member of the Dual-specificity tyrosine …